Literature DB >> 15094224

Cellular retinol-binding protein-1 expression in normal and fibrotic/cirrhotic human liver: different patterns of expression in hepatic stellate cells and (myo)fibroblast subpopulations.

Sébastien Lepreux1, Paulette Bioulac-Sage, Giulio Gabbiani, Vincent Sapin, Chantal Housset, Jean Rosenbaum, Charles Balabaud, Alexis Desmoulière.   

Abstract

BACKGROUND/AIMS: Cellular retinol-binding protein-1 (CRBP-1) which is involved in vitamin A metabolism is highly expressed in liver cells, particularly in hepatic stellate cells (HSCs). In this work, the CRBP-1 expression was studied by immunohistochemistry in the different liver cell populations, including HSCs and portal fibroblasts, of normal liver and of fibrotic and cirrhotic liver.
METHODS: Normal liver, fibrotic liver in different stages and cirrhotic liver sections were studied. Immunohistochemistry was performed using antibodies against CRBP-1, alpha-smooth muscle actin (SMA), CD 68 and CD 34.
RESULTS: In normal liver, quiescent HSCs expressed CRBP-1, while portal fibroblasts did not. In fibrotic or cirrhotic liver, activated HSCs co-expressed CRBP-1 and alpha-SMA; a variable proportion of portal and septal (myo)fibroblasts, more important in cirrhosis, neo-expressed both CRBP-1 and alpha-SMA. Biliary epithelial cells both in normal and pathological situations expressed CRBP-1. Neither Kupffer cells, nor endothelial cells showed CRBP-1 expression.
CONCLUSIONS: Our study demonstrates that CRBP-1 is a good marker to identify HSC in normal human liver. Furthermore, in fibrotic or cirrhotic liver, the different patterns of expression for CRBP-1 and alpha-SMA allow the distinction of different subsets of fibroblastic cells involved in fibrogenesis and septa formation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094224     DOI: 10.1016/j.jhep.2004.01.008

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  18 in total

Review 1.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Smoothelin, a new marker to determine the origin of liver fibrogenic cells.

Authors:  Sébastien Lepreux; Christelle Guyot; Fabrice Billet; Chantal Combe; Charles Balabaud; Paulette Bioulac-Sage; Alexis Desmoulière
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

3.  Identification of markers for quiescent pancreatic stellate cells in the normal human pancreas.

Authors:  Michael Friberg Bruun Nielsen; Michael Bau Mortensen; Sönke Detlefsen
Journal:  Histochem Cell Biol       Date:  2017-05-25       Impact factor: 4.304

4.  Vinculin and cellular retinol-binding protein-1 are markers for quiescent and activated hepatic stellate cells in formalin-fixed paraffin embedded human liver.

Authors:  Elke Van Rossen; Sara Vander Borght; Leo Adrianus van Grunsven; Hendrik Reynaert; Veerle Bruggeman; Rune Blomhoff; Tania Roskams; Albert Geerts
Journal:  Histochem Cell Biol       Date:  2008-12-04       Impact factor: 4.304

Review 5.  The myofibroblast: one function, multiple origins.

Authors:  Boris Hinz; Sem H Phan; Victor J Thannickal; Andrea Galli; Marie-Luce Bochaton-Piallat; Giulio Gabbiani
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

6.  Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells.

Authors:  Frank Tacke; Erwin Gäbele; Frauke Bataille; Robert F Schwabe; Claus Hellerbrand; Frank Klebl; Rainer H Straub; Tom Luedde; Michael P Manns; Christian Trautwein; David A Brenner; Jürgen Schölmerich; Bernd Schnabl
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

Review 7.  Fibrosis in autoimmune and cholestatic liver disease.

Authors:  Melitta Penz-Österreicher; Christoph H Österreicher; Michael Trauner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

8.  Transcriptional profiling of rats subjected to gestational undernourishment: implications for the developmental variations in metabolic traits.

Authors:  Tiffany J Morris; Mark Vickers; Peter Gluckman; Stewart Gilmour; Nabeel Affara
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

9.  Immunohistochemical study of the phenotypic change of the mesenchymal cells during portal tract maturation in normal and fibrous (ductal plate malformation) fetal liver.

Authors:  Julien Villeneuve; Fanny Pelluard-Nehme; Chantal Combe; Dominique Carles; Christine Chaponnier; Jean Ripoche; Charles Balabaud; Paulette Bioulac-Sage; Sébastien Lepreux
Journal:  Comp Hepatol       Date:  2009-07-14

Review 10.  Immune dysfunction in uremia—an update.

Authors:  Gerald Cohen; Walter H Hörl
Journal:  Toxins (Basel)       Date:  2012-10-24       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.